SCHEMBL1743679

SCHEMBL1743679

CC(C)(C)[Si](C)(C)O[C@@H](c1ccc(C(F)(F)F)cc1)[C@@H](CCc1nccs1)NC(=O)O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR139 Q6DWJ6 2/20 0.35
NR3C1 P04150 2/20 0.35
PDE2A O00408 3/20 0.35
FFAR1 O14842 1/20 0.35
CTSA P10619 2/20 0.33
MAPT P10636 2/20 0.33
KMT2A Q03164 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
KDM4E B2RXH2 1/20 0.33
HSP90AA1 P07900 1/20 0.33
HTT P42858 1/20 0.33
MTTP P55157 2/20 0.32
SMO Q99835 2/20 0.32
PTGER4 P35408 1/20 0.32
PTGER2 P43116 1/20 0.32
UTS2R Q9UKP6 1/20 0.32
CTSV O60911 1/20 0.32
CTSS P25774 1/20 0.32
CTSK P43235 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3706895 1.00 GPR139 (0.35) GPR139NR3C1PDE2AFFAR1CTSA
SCHEMBL2548040 1.00 GPR139 (0.35) GPR139NR3C1PDE2AFFAR1CTSA
SCHEMBL12241693 0.90 CTSK (0.37) GPR139NR3C1PDE2AFFAR1KMT2A
SCHEMBL1744300 0.84 CTSA (0.38) GPR139PDE2AFFAR1CTSANPC1
SCHEMBL2548361 0.83 FFAR2 (0.33) PDE2AFFAR1CTSAKMT2APTGER4
SCHEMBL2548358 0.83 FFAR2 (0.33) PDE2AFFAR1CTSAKMT2APTGER4
SCHEMBL2551183 0.83 FFAR1 (0.33) GPR139NR3C1PDE2AFFAR1CTSA
SCHEMBL1595429 0.82 PDE2A (0.39) PDE2A
SCHEMBL1595431 0.82 PDE2A (0.39) PDE2A
SCHEMBL1744761 0.81 CNR2 (0.34) PDE2AFFAR1UTS2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2387570-A1 FLUOROISOQUINOLINE SUBSTITUTED THIAZOLE COMPOUNDS AND METHODS OF USE Amgen, Inc (US) 2011-11-23 EP disclosed
US-20110263647-A1 FLUOROISOQUINOLINE SUBSTITUTED THIAZOLE COMPOUNDS AND METHODS OF USE AMGEN INC. (US) 2011-10-27 US disclosed
WO-2010083246-A1 FLUOROISOQUINOLINE SUBSTITUTED THIAZOLE COMPOUNDS AND METHODS OF USE AMGEN INC. (US) 2010-07-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110263647-A1 FLUOROISOQUINOLINE SUBSTITUTED THIAZOLE COMPOUNDS AND METHODS OF USE TFEB, PCK2, JAK2 GPR139 3413/4885NR3C1 533/4885PDE2A 2083/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.